Opens in a new tab

Palladium Diagnostics Strengthens Leadership Team to Drive Growth and Innovation

Published: November 12, 2024
Estimated Read Time: 2 minutes
Leadership team at Palladium Diagnostics driving growth and innovation.

Las Cruces, NM – November 12, 2024 – Palladium Diagnostics LLC, a leading provider of rapid diagnostic solutions, is excited to announce the appointment of Daniel Levenson as Vice President of Business Development. This strategic addition to the team will further solidify Palladium Diagnostics’ position as a premier provider of end-to-end integrated services for complete point- of-use IVD devices.


In his new role, Mr. Levenson will leverage his extensive industry network and expertise to forge
strategic partnerships with leading companies in the diagnostics industry. He will also drive the
development of new CLIA lab services, including protein purification and assay validation, and
promote Palladium Diagnostics’ existing assay development services.


Mr. Levenson brings a wealth of experience and a proven track record of success in the
diagnostics industry. As the former CEO of Millenia Diagnostics, he led the company’s growth
and development, overseeing the development and commercialization of numerous diagnostic
assays. In addition, he held key scientific roles at BD, Cue Health, and CTK Biotech, where he
contributed to the development of innovative diagnostic solutions, including COVID-19 tests,
influenza assays, and molecular diagnostics on both multiplex lateral flow assays and nucleic
amplification microfluidic devices.


A highlight of Mr. Levenson’s career is his pivotal role in securing funding from the NIH’s RADx
initiative to develop a rapid COVID-19 antigen test. This achievement demonstrates his ability to
identify critical market needs and translate them into innovative solutions.


“We are thrilled to welcome Daniel to the Palladium Diagnostics team,” said Jeff Bauer, CEO of
Palladium Diagnostics. “His extensive experience, leadership skills, and passion for innovation
align perfectly with our vision. We are confident that his contributions will drive significant growth and success for the company.”


To learn more about how Palladium Diagnostics can partner with your organization, contact us here!


About Palladium Diagnostics
Palladium Diagnostics is a cutting-edge company focused on developing and commercializing
innovative rapid diagnostic tests. Our mission is to provide accurate, affordable, and accessible
solutions to healthcare providers and consumers worldwide.

Meet The Author
Resources & Knowledge Base

Other Related Articles

  • Dropper releasing a sample drop onto a lateral flow test cassette

    How to Choose the Right In Vitro Diagnostic (IVD) Consulting Partner

    The right IVD consulting partner saves a diagnostic program months and money. The wrong one gives confident advice that leads nowhere. Here are the questions to ask, the red flags to watch for, and why a partner's ability to execute changes the decision.
    Read More
  • Lateral flow test cassette on a blue background

    What Is In Vitro Diagnostic (IVD) Consulting?

    IVD consulting helps diagnostic companies develop, validate, and commercialize a test. This guide covers what consultants actually do, when to bring one in, and how to tell a credible partner from a confident pitch, especially when the guidance comes from a team that also builds the product.
    Read More
  • Laboratory technician performing blood test with pipette and test kit.

    Verification vs Validation in Lateral Flow Immunoassay Development

    Verification and validation are often used interchangeably in lateral flow assay development — but they address different questions, require different study designs, and produce different documentation. Running them out of order, or conflating them into a single study, creates gaps in the design history file that surface later. This guide breaks down what each stage…
    Read More